Professor of Pediatrics, Immune Disease Institute
Internal Medicine
Dr. Judy Lieberman, MD
|
|
Give Review
Judy Lieberman practices Internal Medicine. He studied medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received 1 awards: "Whos Who in Medicine and Healthcare". Judy Lieberman, MD is a published physician. He has 18 papers published. The most current publication "Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown."
Publications
- Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown.
- miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
- The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation.
- G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments.
- Granzyme B-induced mitochondrial ROS are required for apoptosis.
- Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic Acid binding proteins.
- Distribution of Immune Cells in the Human Cervix and Implications for HIV Transmission.
- Production of highly potent recombinant siRNAs in Escherichia coli.
- Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity.
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells.
- Live or let die: posttranscriptional gene regulation in cell stress and cell death.
- Durable Knockdown and Protection From HIV Transmission in Humanized Mice Treated With Gel-formulated CD4 Aptamer-siRNA Chimeras.
- Efficient and specific gene knockdown by small interfering RNAs produced in bacteria.
- Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach.
- The SET complex acts as a barrier to autointegration of HIV-1.
- Dysregulation of microRNA biogenesis and gene silencing in cancer.
- Harnessing RNA interference for therapy: the silent treatment.
Schools
Harvard Medical School
New England Med Center
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Tufts Medical Center -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Rania M. Seliem, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison S. Witkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sophia A. Virani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Gansner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajan Dewar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brendan D. McNulty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra S. Bailey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen K. Ballen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James W. Levenson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anitha Bhat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevan L. Hartshorn, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|